SONENDO INC (SONX) Stock Price & Overview
NYSE:SONX • US8354311073
The current stock price of SONX is 0.23 USD. Today SONX is down by -4.33%. In the past year, price decreased by -90.3%.
SONX Key Statistics
- Market Cap
- 12.484M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.65
- Dividend Yield
- N/A
SONX Stock Performance
SONX Stock Chart
SONX Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to SONX. When comparing the yearly performance of all stocks, SONX is a bad performer in the overall market: 99.14% of all stocks are doing better.
SONX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to SONX. SONX may be in some trouble as it scores bad on both profitability and health.
SONX Earnings
On November 8, 2023 SONX reported an EPS of -0.08 and a revenue of 8.31M. The company beat EPS expectations (43.98% surprise) and missed revenue expectations (-36.99% surprise).
SONX Forecast & Estimates
9 analysts have analysed SONX and the average price target is 1.75 USD. This implies a price increase of 659.46% is expected in the next year compared to the current price of 0.23.
For the next year, analysts expect an EPS growth of 65.53% and a revenue growth 8.44% for SONX
SONX Groups
Sector & Classification
SONX Financial Highlights
Over the last trailing twelve months SONX reported a non-GAAP Earnings per Share(EPS) of -0.65. The EPS increased by 72.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -68.96% | ||
| ROE | -161.08% | ||
| Debt/Equity | 0.98 |
SONX Ownership
SONX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.75 | 197.553B | ||
| ISRG | INTUITIVE SURGICAL INC | 49.01 | 176.649B | ||
| SYK | STRYKER CORP | 25.37 | 147.075B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.78 | 109.521B | ||
| IDXX | IDEXX LABORATORIES INC | 43.82 | 50.748B | ||
| BDX | BECTON DICKINSON AND CO | 10.86 | 49.634B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.77 | 49.488B | ||
| RMD | RESMED INC | 21.03 | 37.626B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.71 | 35.608B | ||
| DXCM | DEXCOM INC | 28.99 | 28.503B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.35 | 19.416B | ||
| PODD | INSULET CORP | 38.44 | 17.013B | ||
| HOLX | HOLOGIC INC | 15.03 | 16.846B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SONX
Company Profile
Sonendo, Inc. is a medical technology company that has developed and is commercializing the GentleWave System to treat tooth decay. The company is headquartered in Laguna Hills, California and currently employs 244 full-time employees. The company went IPO on 2021-10-29. The Company’s Product segment includes the sales of the GentleWave System console and related accessories and instruments. The GentleWave System, is a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. In addition to its GentleWave Console and single-use procedure instruments (PIs), it also offers ancillary products, such as SoundSeal and its Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown, which facilitates an airtight seal between the PI and the tooth. The Company’s Software segment includes the sales of its software licenses for practice management software to enable an integrated digital office for endodontists.
Company Info
SONENDO INC
26061 Merit Circle, Suite 102
Laguna Hills CALIFORNIA US
CEO: Bjarne Bergheim
Employees: 244
Phone: 18447663636.0
SONENDO INC / SONX FAQ
Can you describe the business of SONENDO INC?
Sonendo, Inc. is a medical technology company that has developed and is commercializing the GentleWave System to treat tooth decay. The company is headquartered in Laguna Hills, California and currently employs 244 full-time employees. The company went IPO on 2021-10-29. The Company’s Product segment includes the sales of the GentleWave System console and related accessories and instruments. The GentleWave System, is a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. In addition to its GentleWave Console and single-use procedure instruments (PIs), it also offers ancillary products, such as SoundSeal and its Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown, which facilitates an airtight seal between the PI and the tooth. The Company’s Software segment includes the sales of its software licenses for practice management software to enable an integrated digital office for endodontists.
What is the stock price of SONENDO INC today?
The current stock price of SONX is 0.23 USD. The price decreased by -4.33% in the last trading session.
Does SONX stock pay dividends?
SONX does not pay a dividend.
What is the ChartMill technical and fundamental rating of SONX stock?
SONX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Is SONENDO INC (SONX) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SONX.
What is the expected growth for SONX stock?
The Revenue of SONENDO INC (SONX) is expected to grow by 8.44% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.